Navigation Links
Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer
Date:4/22/2009

Sutent/Taxol Will Earn Decision Resources' Clinical Gold Standard Status for the Indication by 2012, According to a New Report from Decision Resources

WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed oncologists identify a therapy's effect on overall survival as the attribute that most influences their prescribing decisions in metastatic triple-negative breast cancer. Clinical data and the opinions of interviewed thought leaders indicate that Pfizer's Sutent, in combination with Bristol-Myers Squibb's Taxol, has advantages in this attribute over sales-leading Roche/Chugai's Avastin and Taxol.

The new report entitled Metastatic Triple-Negative Breast Cancer: Physicians Want More-Efficacious Therapies for This Niche CaB Population finds that a therapy that improves progression-free survival for patients would earn a 65 percent patient share in metastatic triple-negative breast cancer in the United States and a 30 percent patient share in Europe, according to surveyed U.S. and European oncologists.

In 2008, Decision Resources' proprietary clinical gold standard for metastatic triple-negative breast cancer was the combination of Avastin and Taxol. Based on available data and expert opinion, the combination of Sutent and Taxol will earn gold-standard status for metastatic triple-negative breast cancer in 2012, following Sutent's approval for the indication in 2010 in the U.S. and Europe.

"Physicians anticipate that the combination of Sutent and Taxol will be more effective than currently available therapies in improving progression-free survival," said Decision Resources Analyst Niamh Murphy, Ph.D. "Interviewed thought leaders indicate that Sutent has shown compelling preclinical data and they are encouraged by clinical trial results of Sutent monotherapy."


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. World Vision Index of Concern: Half of Americans Surveyed Said They Would Be Willing to Pay More Taxes to Combat AIDS
2. Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugais Actemra for Rheumatoid Arthritis
3. Surveyed Neurologists in Both the U.S. and Europe Would Welcome an Antiepileptic Drug That is Administered Once-Daily
4. Half of Full-Time Employees Surveyed Dont Understand Health Insurance Coverage for Cancer-Related Medical Expenses
5. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
6. Less Than Two-Thirds of Surveyed Pharmacy Directors Expect to Reimburse Both Onglyza and Alogliptin Once They are Available for the Treatment of Type 2 Diabetes
7. As a Result of the Jupiter Trial, 65 Percent of Surveyed MCO Pharmacy Directors Will Reimburse Crestor for Patients with Elevated hsCRP
8. Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma
9. Surveyed Experts Indicate That Xarelto Has Advantages Over Lovenox in the Treatment of Venous Thromboembolism in Medically Ill Patients
10. Surveyed Experts Indicate that Biogen Idecs Adentri Has Advantages Over Nitroglycerin in the Treatment of Acute Heart Failure
11. As a Result of the FDA Investigation Into TNF-Alpha Inhibitors, 30 Percent of Surveyed Rheumatologists Have Altered Their Prescription Patterns for Juvenile Idiopathic Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... XenaCare Holdings has announced...ritis Foundation, one of the largest nonprofit org...lic health education. , D...are Holdings, Inc. (OTCBB: XCHO), a company specia... consumer healthcare products, has announced today...
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewswire/...received record-high Thanksgiving traffic numbers,...e Thanksgiving, providing a clear picture of what .... The average Thanksgiving meal in 2009 weighed in...se from last year,s feast. According to the Allrec...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)... , PRINCETON, N.J., Nov. 27 Th...most double over the next 25 years and annual medi...36 billion, up from $113 billion today, according ...betes Care . The National Changing Diabetes ...issioned the analysis by a team from the Universit...
(Date:11/26/2009)... that,s too big or too heavy can lead to strains o... News) -- There may be nothing wrong with stuffing...ant to do the same thing with your suitcase as you...ple were treated in 2008 in U.S. hospital emergenc...al facilities for luggage-related injuries, such a...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2
...ests that exempting bars from community smoking ba...ving bar employment, and that even the most compre... reduction in hospitality jobs. , Researchers hop...sues surrounding smoking-ban proposals. , The st...
...er teasing viewers with the news that a member of ... this season, the latest episode of E!,s hit reali...aled the secrets behind former Olympian and Kardas...he miracle worker who corrected Jenner,s facelift ...
...g organizations decreased costs by an average 1% o...pousal surcharges, and wellness initiatives includ...cGraw Wentworth, Michigan,s largest employee group...alth benefits and trends for the current year amon...
...he major polyphenol found in turmeric, appears to ... of fat tissue in mice and cell models. Researcher...Center on Aging at Tufts University (USDA HNRCA) s...xpansion of fat tissue, which cannot happen unless...
...mber of people awaiting lifesaving organ transplan...ntly more than 100,000 people are on the waiting l...o support donation to become registered donors. T...he importance of organ donation, share stories of ...
...(Nasdaq: CYBX ) today announced that Bryan D. Ol...ality, effective on May 18, 2009. Dr. Olin will l...r. Olin joins Cyberonics from Zeltiq Aesthetics, a...oyed as Executive Director, Failure Analysis, Prod...
Other Medicine News:Health News:Study: Smoking bans do not cause job losses in bars and restaurants 2Health News:Study: Smoking bans do not cause job losses in bars and restaurants 3Health News:Study: Smoking bans do not cause job losses in bars and restaurants 4Health News:Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!'s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenner's New Face 2Health News:Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!'s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenner's New Face 3Health News:McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5% 2Health News:McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5% 3Health News:Turmeric extract suppresses fat tissue growth in rodent models 2Health News:Step to the Plate - Register to Donate Aims to Educate Baseball Fans About the Importance of Organ Donation and Increase Registrations 2Health News:Step to the Plate - Register to Donate Aims to Educate Baseball Fans About the Importance of Organ Donation and Increase Registrations 3Health News:Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality 2
(Date:11/29/2009)... , CHICAGO, Nov. 29 Research...MRI) to study brain activation have found that men...ative stimuli, according to a study presented toda...y of North America (RSNA). ,, "Men may direct m...uli and tend to process them in terms of implicati...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Sieme...neration of its Tim ® (Total imaging matrix)...ng throughput) engine. Both technologies are intro...(T) and the new MAGNETOM Skyra* 3T scanners at the...e Radiological Society of North America (RSNA) fro...
(Date:11/27/2009)... , Another option to prevent illnesses..., SILVER SPRING, Md., Nov. 27 /PRNewswire-USNewswi... approved Agriflu for people ages 18 years and old...btypes A and B. ,, (Logo: http://www.newscom..., manufactured by Novartis Vaccines and Diagnostic...
Breaking Medicine Technology:New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7FDA Approves Agriflu Seasonal Influenza Vaccine 2Luminous Medical Inc Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor 5451 1Luminous Medical Inc Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor 5451 2Holston Valley Ranks No 1 in Tennessee for Cardiology 59411 1Holston Valley Ranks No 1 in Tennessee for Cardiology 59411 2AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2
...affirms Primacy and Safety of ,First Generation, A...Incorporated (Nasdaq: GNTA ) announced the presen...mersen sodium) Injection, its lead anticancer,comp...a brief intravenous,(IV) infusion. The new data we...linical Research, South Texas Accelerated Research...
...ow Improvement in Hemodynamics and Delay Disease P...uticals US, Inc.,today announced positive results ...sentan) may be safe and effective as a combination...ypertension (PAH). Data from both,studies suggest ...enafil,is well-tolerated and improves hemodynamics...
Other Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
IDS Rapid SS/u
Versatrek 240
ELP 40
96 PW Microplate Washer
Medicine Products: